Brookline Capital Acquisition Corp.
0.0M
-
-203.92
$-0.05
No price alerts set. Add an alert to get notified!
-203.92
15,516,958.92
$-0.05
-628.34%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
ACAQ
Athena Consumer Acquisition Corp.
|
$2.55 | -70.72% | -35.48 | $25.69M | 0.00 |
|
ALSA
Alpha Star Acquisition Corporation
|
$12.06 | 0.00 | -0.56 | $27.33M | -0.34 |
|
AQU
Aquaron Acquisition Corp.
|
$11.68 | -0.60% | -1.44 | $28.36M | 0.00 |
|
DUNE
Dune Acquisition Corporation
|
$4.05 | -12.34% | -0.22 | $22.25M | 0.00 |
|
ESLA
Estrella Immunopharma, Inc.
|
$1.09 | -1.80% | -3.00 | $45.82M | 0.00 |
|
FNVT
Finnovate Acquisition Corp.
|
$11.62 | 0.00% | -30.27 | $25.93M | 0.00 |
|
HUDA
Hudson Acquisition I Corp.
|
$12.55 | -1.80% | -2.12 | $27.37M | -0.42 |
|
KYCH
Keyarch Acquisition Corporation
|
$4.10 | 0.00 | -0.49 | $24.24M | 0.17 |
* Peer stocks are selected based on market capitalization and sector
-
-
$0.00
0.00%
Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
